Columbus A/S
30.3.2026 09:41:38 CEST | Globenewswire | Press release
Columbus – Weekly report on share buyback
Columbus – Weekly report on share buyback
Company announcement no. 27/2026
Transactions in the period 23 March to 27 March 2026
On 12 March 2026, Columbus A/S announced a share buyback programme under which the company will repurchase shares for up to DKK 25m during the period from 12 March 2026 to 3 March 2027, as outlined in company announcement no. 14/2026.
The share buyback programme is executed in accordance with Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (market abuse regulation) and the Commission Delegated Regulation (EU) 2016/1052, also referred to as the Safe Harbour Regulations.
The following transactions were made under the share buyback programme in the period 23 March to 27 March 2026:
With the transactions stated above, Columbus A/S holds a total of 1,763,536 own shares, corresponding to 1.36% of the Company’s share capital.
For further information, please contact: CFO, Brian Iversen, +45 70 20 50 00 |
Attachments
- SE_27_2026_Weekly_report_on_share_buyback
- Columbus-Share buyback transactions 23 March 2026 to 27 March 2026
Documents
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
SERB Pharmaceuticals23.10.2026 21:01:27 CEST | Press release
SERB Pharmaceuticals Announces Positive Results from the Post-Authorisation Efficacy Study of Idefirix® (imlifidase) Presented at ASN Kidney Week 2026
F. Hoffmann-La Roche Ltd23.10.2026 19:30:00 CEST | Press release
Roche presents interim phase III data showing sefaxersen significantly reduced proteinuria in people with IgA nephropathy (IgAN)
TecDo Technology Co., Limited23.10.2026 18:37:22 CEST | Press release
TGC 2026: Tec-Do Launches Navos Pro for Results-Driven AI for Work
CGTN23.10.2026 18:17:10 CEST | Pressemeddelelse
CGTN: Hvad fortæller historien om 'Half a Quilt' (Et halvt vattæppe) os om Kinas nye lange march?
Genmab A/S23.10.2026 17:55:00 CEST | Press release
Genmab Announces Rinatabart Sesutecan (Rina-S®) Demonstrates Statistically Significant Improvement in Progression-Free Survival and Overall Survival in Patients with Platinum-Resistant Ovarian Cancer
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom